Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xu Yang, Amin Liu, Lin Yang, Tiantian Wen, Jia Wang, Jingmiao Shi, Hui Zhou, Zhimeng Chen, Meng Lei & Yongqiang Zhu. (2022) Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome Inhibitor. Drug Design, Development and Therapy 16, pages 3087-3107.
Read now
Read now
Pasquale Niscola, Laura Scaramucci & Fabio Efficace. (2019) Towards the integration of patient-reported outcomes into the global clinical management of multiple myeloma. Expert Review of Hematology 12:9, pages 703-705.
Read now
Read now
Hailong Tang, Mimi Shu, Bo Dai, Li Xu, Baoxia Dong, Guangxun Gao & Xiequn Chen. (2018) DNA damage response-initiated cytokine secretion in bone marrow stromal cells promotes chemoresistance of myeloma cells. Leukemia & Lymphoma 59:9, pages 2220-2226.
Read now
Read now
Marco Salvini, Rossella Troia, Davide Giudice, Chiara Pautasso, Mario Boccadoro & Alessandra Larocca. (2018) Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma. Expert Opinion on Drug Metabolism & Toxicology 14:1, pages 91-99.
Read now
Read now
Articles from other publishers (6)
Heinz Ludwig, Abigail Lucy Bailey, Andrea Marongiu, Keerun Khela, Gary Milligan, Katherine Brewer Carlson, Alex Rider & Anouchka Seesaghur. (2021) Patient‐reported pain severity and health‐related quality of life in patients with multiple myeloma in real world clinical practice. Cancer Reports 5:1.
Crossref
Crossref
Vikas A. Gupta, Benjamin G. Barwick, Shannon M. MatulisRyosuke ShirasakiDavid L. Jaye, Jonathan J. Keats, Benjamin OberltonNisha S. JosephCraig C. Hofmeister, Leonard T. HeffnerMadhav V. DhodapkarAjay K. NookaSagar LonialConstantine S. MitsiadesJonathan L. KaufmanLawrence H. Boise. (2021) Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression. Blood 137:26, pages 3604-3615.
Crossref
Crossref
Simon J. Fifer, Kerrie-Anne Ho, Sean Lybrand, Laurie J. Axford & Steve Roach. (2020) Alignment of preferences in the treatment of multiple myeloma – a discrete choice experiment of patient, carer, physician, and nurse preferences. BMC Cancer 20:1.
Crossref
Crossref
Franco Dammacco, Patrizia Leone, Franco Silvestris, Vito Racanelli & Angelo Vacca. 2019. Oncogenomics. Oncogenomics
121
137
.
Dai Maruyama, Kensei Tobinai, Takaaki Chou, Masafumi Taniwaki, Yoshihisa Shumiya & Shinsuke Iida. (2018) Weekly carfilzomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma: A phase 1 and PK/PD trial. Cancer Science 109:10, pages 3245-3252.
Crossref
Crossref
Ali Dehghanifard, Saeid Kaviani, Saeid Abroun, Mahshad Mehdizadeh, Sajedeh Saiedi, Amirhosein Maali, Sasan Ghaffari & Mehdi Azad. (2018) Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways. Clinical Lymphoma Myeloma and Leukemia 18:5, pages 311-320.
Crossref
Crossref